NIESOR, JOSEPH ERIC,BENGHOZI, RENEE,LAMOUR, FRANCOIS
申请号：
CA3032229
公开号：
CA3032229A1
申请日:
2017.07.26
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
The present invention is related to a combination useful in the prevention and/or treatment of red blood cell disorders, in particular, acute and chronic complications associated with red blood cell dysfunction, increased red blood cell cholesterol and decreased plasma levels of lipophilic antioxidant (sickle cell disease, thalassemia, diabetes). The invention in particular relates to pharmaceutical formulations, regimens, methods of treatment and uses thereof.
